Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients.

Endometrial cancer Lymphadenectomy Outcome Sentinel node Surgery

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
17 Jan 2024
Historique:
received: 28 08 2023
revised: 27 12 2023
accepted: 08 01 2024
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 29 1 2024
Statut: aheadofprint

Résumé

The role of nodal dissection in patients with endometrial cancer has been intensively studied in several studies. Historically, systematic pelvic and para-aortic lymphadenectomy represented the gold standard surgical treatment to assess potential nodal involvement and consequently define the appropriate stage of the tumor. Over the last years, sentinel node biopsy (SLNB) has been introduced as a more targeted alternative to lymph node dissection for lymph node staging and it has become popular among gynecologic oncologists. However, no level A evidence is still available, and several features of the SLNB technique have been matter of discussion among clinicians and a universally accepted methodology is still not currently available. This narrative review aims to summarize the body of knowledge on SLNB to offer the reader a complete picture about the evolution of this technique over the last decades.

Identifiants

pubmed: 38286085
pii: S0748-7983(24)00008-8
doi: 10.1016/j.ejso.2024.107956
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107956

Informations de copyright

© 2024 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Umberto Leone Roberti Maggiore (U)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address: ulrm@me.com.

Ludovica Spanò Bascio (L)

Obstetrics and Gynecology, Policlinico Modena, University of Modena and Reggio Emilia, Modena, Italy.

Carlo Alboni (C)

Obstetrics and Gynecology, Policlinico Modena, University of Modena and Reggio Emilia, Modena, Italy.

Giulia Chiarello (G)

Department of Biomedical Sciences and Human Oncology, University of Bari, Italy.

Luca Savelli (L)

Obstetrics and Gynecology Unit, Morgagni-Pierantoni Hospital, Forlì, Italy.

Giorgio Bogani (G)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Fabio Martinelli (F)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Valentina Chiappa (V)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Antonino Ditto (A)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Francesco Raspagliesi (F)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Classifications MeSH